chrisvoncsefalvay/vaers-outcomes huggingface dataset:
I had continuous headaches pain scale 5 and SOB where Ive needed to use an inhaler.; I had continuous headaches pain scale 5 and SOB where Ive needed to use an inhaler.; This is a spontaneous report from a contactable  other HCP reporting for herself.    A 45-years-old female patient received the first dose of bnt162b2 (BNT162B2) vaccine  , intramuscular in the left arm on 11Jan2021 15:30 at SINGLE DOSE for covid-19 immunisation .  Medical history included thyroid disorder and  rubber sensitivity (Allergy: Latex).  The patient  had continuous headaches pain scale 5 and Shortness of Breath (SOB) on 12Jan2021 12:00 with outcome of recovered with sequelae. The patient received Tylenol  and an inhaler as treatment of the events.  Lot number information have been requested.
Became very dizzy and fatigued, vomited until bile was present, symptoms persisted until Saturday. Sunday morning took Motrin for headache. Tired, but not exhausted. No symptoms on Monday.
This case was reported by an other Health Professional and described the occurrence of extra dose administered in a 5-year-old patient who received KINRIX. Concomitant products included KINRIX. On an unknown date, the patient received the 2nd dose of KINRIX. On an unknown date, an unknown time after receiving KINRIX and KINRIX, the patient experienced extra dose administered. On an unknown date, the outcome of the extra dose administered was unknown. It was unknown if the reporter considered the extra dose administered to be related to KINRIX. Additional information received on 29 September 2014: The patient was inadvertently administered KINRIX 4 days after a previous dose of KINRIX.
This spontaneous report as received from a nurse refers to a 16 year old female patient. Information on the patient's concurrent conditions, medical history and concomitant medications was reported. On 11-FEB-2019, the patient was vaccinated with improperly stored doses of RECOMBIVAX HB injection 5/0.5 mcrg/ml (frequency, route of administration was not reported; lot # R012001, expiration date 06-NOV-2020) for prophylaxis. The temperature of excursion with RECOMBIVAX HB was above 9 Celsius degrees for 1 hour and 36 minutes. No previous temperature of excursion was performed. The temperature of excursion was detected by a data logger. No adverse effects were reported. This is one of several cases from the same reporter. Sender's Comments: US-009507513-1902USA007125: US-009507513-1902USA006504.
On 01/22/2021 around 2 PM I noticed the spot between my clavicle was tender and it was that way for a couple days. I didn't take any  medicine, only monitored. It subsided by that following Monday 01/25/2021 and It was completely gone by then. I did not see my PCP but my friend that is a nurse said that I could have sub clavicular lymph nodes.
After 45 min. pt complains about swelling of the throat, I did not see anything, so I asked pt to go to an urgent care close to us - > she had epipen and bec. after almost 1 1/2 she developed swelling of the face and lips -> was treated and know she is fine.
Patient reported an anaphylactic reaction  (throat swelling, trouble breathing) to ibuprofen. She also indicated she developed a rash all over her body to a flu vaccine in 1970s, attributed to her egg allergy. Due to her extensive allergies and the fact that she has not gotten a vaccine since 1970s, I would need to monitor her for 30 minutes. (Even though none of her allergies cross react with ingredients in covid Pfizer vaccine. I gave patient vaccine and had her sit in waiting  room to be monitored. After 5 or so minutes I noticed her head down, I asked if she was feeling okay she said yes just very tired. I asked if any trouble breathing she said no but her mouth feels dry. Another five minutes go by and patients head is down again, I again ask if she is okay she says yes just very tired and she wasn't before vaccine. I ask if any trouble breathing/swallowing, she said it's a little hard to swallow but she thinks its because her mouth is dry. I get patient a water and ask if she is okay if I give her a Benadryl. She says yes so I give her 50mg Benadryl by mouth. Another 5 minutes go by and again I have to ask patient how she was feeling, she said fine. I ask how her throat is, she says it just feels kind of tight. Due to this progression of allergic reaction (although slow, clearly progressing)  I told patient I will have to call for an ambulance. Paramedics showed up after 5-10 minutes and took care of patient. I relayed all this info to them as well as the dispatcher on the phone. Paramedics took patient to hospital conscious and breathing on her own.
Patient is was under given the Janssen but was under 18 years.  No side effect has been reported as the number on file is unreachable.
Client received pneumo vaccine on 11/7/14 on left deltoid, swelling on deltoid then had "big ball" on deltoid, that night traveled down to inner elbow with swelling, redness and pain, and continues.
T104 @ 5AM 8/2/99 1045AM-30sec generalized sz;no temp documented in ER;
Did not feel well after receiving the vaccine. Felt shortness of breath, which ended quickly, lump in throat, tingling of skin, facial throat and inside mouth tingling sensation. Experienced nausea. On the 03/17/2010 my skin was blotchy, and felt a little dizzy.
Pt. recv. vax. and exp. rash, blisters, deep muscle pain at injection site.  Pt. exp. erupting blisters, pain radiating up and down arm.  Red ring moving into shoulder muscles wasting into shoulder, neck across other shoulder down to elbow.
9-days after receiving vaccination the area turned red, severe itching, raised bumps, swelling, warm to touch and aching down to elbow. One week later after having reaction, still slight itching and a few raised bumps.
Patient was given their first dose of the Moderna COVIDvaccine. Within 1 minute, the patient began having a seizure (jerking, eyes rolled back in the head,  head went limp, and his body stiffed up), and then went unconscious.
15mins post vaccination, pt c/o chest tightness and increased HR.  Pt also felt hungry. Vitals: BP 120/84, HR 84, RR 18, O2sat 100% -- > @12:50 116/86, 83, 18, 100%. Pt given juice, crackers and water @12:52 pt stable and released from the vaccination site.  Pt received booster Moderna.  Primary series w/ Pfizer
This spontaneous report as received from a pharmacist refers to a currently 24 year old male patient with no relevant medical history nor current conditions. On 11-OCT-2014 the patient was vaccinated with the first dose of GARDASIL (route, lot number and expiration date were not reported). On 20-DEC-2014, the patient received a second dose of GARDASIL lot # 0324AE, expiration date: 20-OCT-2014 (dose and route were not reported). After vaccination the pharmacist noticed the vaccine was expired. Patient had none concomitant medication. It was unknown if the patient could continue to get the third GARDASIL injection. Additional information has been requested.
Per grandmother, infant had rash appear approx 8 days after vaccines given. Appeared on abdomen, back and 1 spot on face. States "very minor rash". Daughter took to ER and was diagnosed as a "viral rash". Resolved in 3 days with no problems.
mild fever (99.5F), severe joint and muscle aches, severe fatigue, severe arm pain.
In the early morning around 3:00 a.m. presented swelling in the eyes, numbness of the tongue, swollen mouth and tingling in the face. where it took a Benadryl at the time.
Generalized Weakness, lodd ofL.E.function, Hospitalized 08/26/01, dx with GBS
At the time of vaccination, I had a stitch in my hand from a biopsy to diagnose Eczema (which at that time had ONLY shown as a skin rash on the palms of my hands).  Approximately 1-2 weeks post vaccination, when my stitch was removed, several instenely itchy blisters appeared on the palm around the stitch site. Also, approximately 2-3 weeks post vaccination, some of my nails lost their cuticles, some nails became pitted and unhealthy and several began to separate from the nailbed. A dermatologist prescribed steroid ointment and nightly aquaphor application as well as biotin. The nails have continued to deteriorate and have not improved regardless of 2-3 months of aquaphor application and 2 rounds of topical steroid treatment.
This spontaneous case reported by a consumer, describes the occurrence of fatigue (tired after booster dose) and myalgia (sore after booster dose) in a 73-year-old male patient who received mRNA-1273 (Moderna COVID-19 vaccine) for COVID-19 immunization. The patient's past medical history included cancer (removed from his hand and face) on Dec 9, 2020. On Dec 9, 2021, patient received the third dose of mRNA-1273 (Moderna COVID-19 vaccine), unknown route; 1 dosage form. On Dec 9, 2021, patient experienced fatigue (tired after booster dose) and myalgia (sore after booster dose). At the time of the report, fatigue (tired after booster dose) and myalgia (sore after booster dose) outcome: unknown. No concomitant medication or treatment information provided. This case linked to MOD-2021-409887, MOD-2021-409903 (patient link).
Received Tdap and meningitis vaccines. Several minutes later became pale, said he didn't feel well. Became unresponsive for < 1 minute. Condition was closely monitored for next 15 minutes. Left building unassisted with mother and siblings.
Dizziness at 3:30am on 12/2. Redness and pain at injection site 12/2
Information has been received from a nurse concerning a 5-year-old female who on 05-JUL-2007 was vaccinated with a second dose of varicella virus vaccine live (Oka/Merck). Her first dose of varicella virus vaccine live (Oka/Merck) was administered at 12-15 months of age in approximately 2003. It is reported that approximately in August 2007, "the patient was experiencing a mild breakthrough of chickenpox" on her trunk and legs. She was seen at the physicians office and given Benadryl to treat the symptoms. The outcome was reported as recovering. No product quality complaint was involved. The physician also reported that the patient's sibling developed chickenpox following vaccine administration (WAES numbers: 0708USA05499). This is one of several reports from the same reporter. Additional information has been requested.
Epi Pen refill during same hospital stay where patient was given first COVID dose. Hospital admission was for behavioral health.
Patient received RSV (arexvy) and Moderna covid vaccine both in left deltoid on 10/25/23 around 11am.  Patient states around 10pm on 10/25/23 she had a sore arm, felt achy, tired, vomited, had no appetite, fever of 103, and cold sores on both upper and bottom lips and canker sores inside her mouth.  The 103 fever lasted for 2 days and then 102 fever for 1 day.  As of today, 11/9/23 she states she is still recovering and does not feel back to normal as of yet.
Information has been received from a physician concerning a 44 year old patient who on an unspecified date was vaccinated with Zostavax (Oka/Merck), 0.5 ml, subcutaneously, instead of Varivax (Oka/Merck).  No adverse experience was related to this event.  It was reported that it was not due to product confusion but to a medical error.  Additional information has been requested.
I am 77 yrs old, male , ,  150# and 5ft 6inches...Within 24 hours of receiving the shot, my body thru-up clots in my left leg. and I spent 4 days in the hospital ( 3 days in surgical ICU), breaking up the clots to save the leg. This is too much of a coincidence to ignore and I will not receive the 2nd shot.
Pt. called says she has severe pain from top of arm to wrist. Took 2 NORCO and it still hurt. No swelling, or redness, trouble moving arm.
Information has been received from a health professional concerning a female who on an unspecified date was vaccinated with the first dose of GARDASIL vaccine (yeast) (Lot # 656051/0244U), 0.5 mL, IM. On an unspecified date the patient was vaccinated with the second dose of GARDASIL vaccine (yeast) (Lot # 657736/0389U), 0.5 mL, IM. Recently, in 2008, the patient was diagnosed with postural orthostatic tachycardia syndrome, EKG and table tilt test were both positive for Postural Orthostatic Tachycardia Syndrome. The patient had not recovered from postural orthostatic tachycardia syndrome. The patient sought medical attention, in physician's office. Additional information has been requested.
Itchy nose, arm swelling and redness about 8 cm below the injection site.  No shortness of breath or wheezing.
This case was reported by a pharmacist via call center representative and described the occurrence of muscle pain in a 59-year-old male patient who received SHINGRIX (batch number B5EK2, expiry date 28th April 2020). On 22nd March 2018, the patient received SHINGRIX .5 ml. On 23rd March 2018, 1 days after receiving SHINGRIX, the patient experienced muscle pain. In March 2018, the outcome of the muscle pain was recovered/resolved. The reporter considered the muscle pain to be probably related to SHINGRIX. Additional details were provided as follows: The patient received SHINGRIX in left arm. The registered pharmacist reported that, this patient said he always got muscle aches after a vaccination. The registered pharmacist reported this to VAERS. This case is 1 of 4 cases reported by same reporter.
4/25/18 - 1st shot of SHINGRIX vaccine. Sick for 2 days with muscle pain, fatigue, nausea, headache, shivering, chills. 9/11/18 - 2nd shot of SHINGRIX. Sick for 4 days with the same symptoms, only more severe. 9/27/18 - Woke up with right eye vision loss. Had an appointment to pick up contacts so Dr. did a full eye exam. Could only see the top of the big E. Had a visual field test 9/28/18 - Saw Dr. in ophthalmology. Diagnosed ION, although I don't have any of the normal risk factors of diabetes, hypertension, or sleep apnea. 10/7/18 - Experiencing the same symptoms as right after the shots, chills, headache, dizziness, muscle aches and fatigue. Dr. had me come to ER for the MRIs that night 10/8/18 - Saw Dr.  I couldn't see his hand with my right eye 2 inches from my face. Had visual field test. Saw Dr (retina specialist). He gave me a shot of Avastin. 10/10/18 - Started on 60 mg of Prednisone 10/17/18 - Saw Dr. at the Eye Institute. Showed him article. Dr. found 3 other cases like mine of ION in the trials. See Testimony on SHINGRIX dated September 13, 2017. 10/18/18, 10/19/18, 10/20/18 - infusions of 1000 mg of Prednisone 10/21/18 - back on 60 mg Prednisone Diagnosis:  Edema of optic disc of right eye, Ischemic optic neuropathy of right eye, Macular retinal edema, Nuclear sclerosis of both eyes.
Patient received the vaccination in the afternoon. That night she started experiencing chills and was running a fever of 103. The fever continued for two more days, and then broke. She  took Tylenol and ibuprofen as needed for the pain and fever. Site of injection and beyond was swollen, red, hot to the touch. She went to urgent care on the third night and was given Benadryl, told to take Claritin as well and the area was mapped out on her arm to watch for spreading. Currently it is spreading beyond the lines mapped out, she is going to follow up with urgent care as soon as possible.
This spontaneous report as received from medical assistant refers to multiple unspecified patients of unknown age and gender. Information on pertinent medical history and concurrent condition was not provided. On an unspecified dates, the patients were vaccinated with improperly stored doses of GARDASIL 9 lot # N004799, expiry 15-NOV-2019 (dose and route not reported) for prophylaxis.  It was reported that on unspecified dates, the vaccine was exposed to a temperature between 2 Centigrade degrees and 8 Centigrade degrees (1.8C) for 42 minutes. There was previous temperature excursion between 0 Centigrade degrees and 1 Centigrade degree for 1 hour and 56 minutes and another excursion between 9 and 25 Centigrade degrees (11.4C) for 1 hour and 41 minutes. The call was placed because of a Digital Data logger report. No adverse effects reported. As of 01-SEP-2017, all telephone attempts to obtain follow up information had been unsuccessful. Follow up information has been received from the medical assistant on 05-SEP-2017. The patient's age was confirmed as 14 years. It was also confirmed that on 07-AUG-2017 the patient was vaccinated with the improperly stored GARDASIL 9 lot # M044717 (previously reported as lot # N004799). This is one of several reports received from the same reporter.; Sender's Comments: US-009507513-1709USA005737: US-009507513-1709USA005738: US-009507513-1709USA005747: US-009507513-1709USA005740: US-009507513-1708USA001768: US-009507513-1709USA005742: US-009507513-1709USA005743: US-009507513-1709USA005744: US-009507513-1709USA005745: US-009507513-1709USA005746: US-009507513-1709USA005736: US-009507513-1709USA005735: US-009507513-1709USA005748: US-009507513-1709USA005739:
Immunizations given 02/10/2005.  Rash broke out 02/12/2005 - Benadryl, Grandmother saw nurse practitioner on 02/17/2005 who stated it was reaction to shots.
5 minutes after I received the shot my left pinky finger and left ring finger went numb. I notified the nurse. She left to get the head nurse. Within 2 minutes my arm was numb below my elbow. This lasted 10 minutes. The feeling came back. Later that day my left upper back was sore. Since then (2 weeks) I still have numbness and tingling in my elbow and left pinky finger with occasional pain in my left upper back.
An expired dose (expiration date of 8Oct2021) of the Moderna Covid-19 Vaccine was given to a patient on 21Oct2021; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (An expired dose (expiration date of 8Oct2021) of the Moderna Covid-19 Vaccine was given to a patient on 21Oct2021) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 045B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 21-Oct-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 21-Oct-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (An expired dose (expiration date of 8Oct2021) of the Moderna Covid-19 Vaccine was given to a patient on 21Oct2021). On 21-Oct-2021, EXPIRED PRODUCT ADMINISTERED (An expired dose (expiration date of 8Oct2021) of the Moderna Covid-19 Vaccine was given to a patient on 21Oct2021) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications was reported.  No treatment drug details was reported.
I am 27 weeks pregnant; This spontaneous prospective pregnancy case was reported by a consumer and describes the occurrence of MATERNAL EXPOSURE DURING PREGNANCY (I am 27 weeks pregnant) in a 32-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 04-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. The patient's last menstrual period was on an unknown date and the estimated date of delivery was 04-Apr-2021. On 04-Jan-2021, the patient experienced MATERNAL EXPOSURE DURING PREGNANCY (I am 27 weeks pregnant). The delivery occurred on an unknown date, which was reported as Unknown. For neonate 1, The outcome was reported as Unknown. On 04-Jan-2021, MATERNAL EXPOSURE DURING PREGNANCY (I am 27 weeks pregnant) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant and treatment medications were not reported.; Sender's Comments: This is a case of product exposure during pregnancy with no associated AEs for this 32-year-old female patient. Patient will continue to be contacted for further monitoring of AEs during the pregnancy.
Patient began seizing approximately 10 minutes after administration of 1st Pfizer dose. Patient fell, but did not hit his head on the ground, was seizing for about 3 minutes and then regained consciousness.
Day 1 late afternoon feverish and headache lasted approximately 2-3 hours went away without medication. Day 2 arm very sore from shoulder to elbow, was better by day 3. Day 3 around 11am left tricep started twitching only twice for about 1minute, later that night abdomen was twitching it woke me up ! lasted a couple minutes, next morning left quadricep was twitching for about 1 minute later muscle under left eye lasted off and on for a few minutes.  Finally no more twitches !!
Information has been received from a physician concerning a patient who on an unknown date was vaccinated with a second dose of VARIVAX (Merck). On an unspecified date, 10 days post vaccination, the patient developed a rash. The rash was found to be positive for the vaccine strain VZV by PCR performed at the CDC. At the time of the report the patient's status was unknown. A product quality complaint was not involved. The reporting physician stated she believes there has been an increase in the frequency of calls to the local health department regarding second dose AEs, particularly rashes in patients who have received a second dose of VARIVAX (Merck). She indicated that other physicians in the region also felt they were seeing an increase in second dose rashes as compared to what they observed following the first dose. With respect to specific types of AEs, the physician stated she saw reports of generalized rashes, injection site reactions and cellulitis. She has spoken with the reporting healthcare providers and all doses of VARIVAX (Merck) were stored and administered appropriately, and all patients involved were normal healthy children. This is one of several reports received from the same source. Additional information has been requested.
having some effects like nausea; This spontaneous case was reported by a consumer and describes the occurrence of NAUSEA (having some effects like nausea) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Ulcer.    On 05-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 06-Mar-2021, the patient experienced NAUSEA (having some effects like nausea). At the time of the report, NAUSEA (having some effects like nausea) had not resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       Reporter did not allow further contact
Patient given high dose flu vaccine when underage, guidelines of 65 and up patient was 64 when vaccine was given.  No adverse symptoms identified after giving vaccine and upon patient interview.
I saw a flare-up of red boils on the right side of my chest, upper side. I thought it as heat bubbles and I waited. It started to look like it had fluid in them. I went to the pharmacy for diagnosis. I met with a Registered Nurse and who looked at it, and she inspected it and was pretty sure it was Shingles. Gave me over the counter medicine for a week and prescribed something for 1-2 weeks. It took it's time in resolving. I had it for at least 2 weeks and then resolved on its own. I have marks on my chest right now but shingles are completely gone. It affected my ability to be productive, for a couple days or so. If a cloth were even to touch it, it would be insanely painful.
Patient has a history of absent seizures.  Patient slumped in her chair slightly and was slightly confused in responses. Patient Returned to normal after 15-30 minutes.
2 minutes after injection patient reported burning feeling in body.  Topical non macular rash appeared on R lower arm, reports itchy feeling on skin generalized.  VS WNL.  No SOB, respiratory distress, or site reaction symptoms noted.  No throat swelling or tingling.  Patient observed and Dr. notified.  No treatment necessary.
Myalgia, Rash, myalgia and redness that seemed to resolve, followed by cellulitis with ring like lesion. monitoring for other SJS rash Narrative:  required use of antibiotics.